Abstract In 2011, the National Institute on Aging and Alzheimer's Association created
separate diagnostic recommendations for the preclinical, mild cognitive impairment, and …

The aim of a clinical classification of pulmonary hypertension (PH) is to group together
different manifestations of disease sharing similarities in pathophysiologic mechanisms …

Background: Wildfire activity is predicted to increase in many parts of the world due to
changes in temperature and precipitation patterns from global climate change. Wildfire …

Background—Factors that determine survival in pulmonary arterial hypertension (PAH) drive
clinical management. A quantitative survival prediction tool has not been established for …

The following study addresses most of the issues raised by critics of profile interpretation,
and also aims to identify a number of distinct profiles of DAS cluster scores among groups of …

Background: Pulmonary hypertension is a progressive and often fatal complication of the
scleroderma spectrum of disease for which no treatment has been proven effective in a …

Enhancing Quality of Life (QOL) has long been an explicit or implicit goal for individuals,
communities, nations, and the world. But defining QOL and measuring progress toward …

Background Standard therapy to prevent recurrent venous thromboembolism includes 3 to
12 months of treatment with full-dose warfarin with a target international normalized ratio …

Background The Registry to EValuate Early And Long-term pulmonary arterial hypertension
disease management (REVEAL Registry) was established to provide updated …

Background Patients with acute carbon monoxide poisoning commonly have cognitive
sequelae. We conducted a double-blind, randomized trial to evaluate the effect of hyperbaric …